NCT06587438Active, not recruiting
Effect of CGM on Glucose Control in Non-insulin-treated Patients With Type 2 Diabetes Mellitus
Effects of COntinuous Glucose moNitoring Versus Usual Care on glycEmic Control in Non-insulin-tReated Adults With Type 2 Diabetes：a Multi-center Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 6 Aug 2026
Brief summary (registry, in English)
The clinical value of CGM for diabetic patients undergoing insulin therapy has been widely recognized, but the evidence-based support for its use in non-insulin-treated type 2 diabetic patients remains insufficient. The primary objective of this study is to evaluate the effect of real-time continuous glucose monitoring (CGM) compared with self-monitoring of blood glucose on glycemic control in adults with non-insulin treated type 2 diabetes.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 160 (actual)
- First submitted
- 4 Sept 2024
- Start date
- 17 Jan 2025
- Primary completion date
- 14 Mar 2026
- Lead sponsor
- Sinocare
- Diseases
- Type 2 diabetes
- NCT number
- NCT06587438
What you commit to
- Study type: Interventional
- Participants enrolled: 160
- From 17 Jan 2025 to the primary completion date, 14 Mar 2026
- 6 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- (1)Patients treated with insulin within 3 months prior to screening
- (2)Currently or have used a CGM device within 3 months prior to enrollment
Other illness
- (3)Serious skin disease at the sensor placement site, allergy to tape or adhesives
- (6)Those who, in the opinion of the investigator, should not participate in this clinical trial, such as: ①those who have a history of eye trauma or other diagnosed eye diseases resulting in visual impairment, etc.; ②those who are unwilling or unable to fully understand or cooperate due to speech disorders; ③those who suffer from mental disorders
Other
- (4)Pregnant females, those with a positive pregnancy test result at screening, or those who plan to become pregnant during the study
- (5)Those who are participating or will participate in other clinical trials
Who the study is looking for
- (1)Subjects aged ≥18 years at screening (based on the day of signing the informed consent form) and of any gender
- (2)Patients diagnosed with type 2 diabetes
- (3)Prior to the screening, glycemic control was suboptimal with diet, exercise control, and oral medication or glucagon-like peptide-1RA (GLP-1RA) therapy maintained for more than 3 months, 7.5%≤HbA1c≤10%
- (4)Subjects voluntarily sign an informed consent form
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (6)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Beijing Hospital Coordinator of this site? Confirm its status | Beijing | China | Unknown status |
| The First Affiliated Hospital of Chongqing Medical University Coordinator of this site? Confirm its status | Chongqing | China | Unknown status |
| Qilu Hospital of Shandong University Coordinator of this site? Confirm its status | Jinan | China | Unknown status |
| Shanghai Sixth People's Hospital Coordinator of this site? Confirm its status | Shanghai | China | Unknown status |
| The Eighth Affiliated Hospital of Southern Medical University Coordinator of this site? Confirm its status | Shunde | China | Unknown status |
| Renmin Hospital of Wuhan University/Hubei General Hospital Coordinator of this site? Confirm its status | Wuhan | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.